Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Margaret Ekins Smith currently holds 1,001,738 shares of ARS Pharmaceuticals, Inc. (SPRY), valued at approximately $0. This represents their equity stake as Chief Commercial Officer.
Based on SEC Form 4 filings, Margaret Ekins Smith has been a net neutral trader of SPRY stock. They have purchased $0 and sold $0 worth of shares.
Margaret Ekins Smith's most recent insider trade was on Sep 1, 2026, when they sold 1,001,738 shares at $0.00 per share.
Margaret Ekins Smith serves as Chief Commercial Officer at ARS Pharmaceuticals, Inc. (SPRY). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Margaret Ekins Smith holds the position of Chief Commercial Officer at ARS Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Margaret Ekins Smith has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Margaret Ekins Smith was on Sep 1, 2026, when they purchased $0 worth of SPRY shares. This transaction involved 1,001,738 shares at N/A per share.
Margaret Ekins Smith currently owns 1,001,738 shares of ARS Pharmaceuticals, Inc. (SPRY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Margaret Ekins Smith's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Margaret Ekins Smith has 1 Form 4 filings on record as an insider at ARS Pharmaceuticals, Inc..
Set alerts for Margaret Ekins Smith and 40,000+ other insiders.